Correction to: Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604)

L. C. Sullivan; T. A. Chavera; X. Gao; M. M. Pando; Kelly A Berg

doi:10.1124/jpet.112.241604err

Correction to: Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604)

L. C. Sullivan, T. A. Chavera, X. Gao, M. M. Pando, Kelly A Berg

Research output: Contribution to journal › Comment/debate

Abstract

J Pharmacol Exp Ther 362(1):200–209; DOI: 10.1124/jpet.117.241604], the following funding information was omitted: This work was supported by U.S. Public Health Service grants from the National Institutes of Health National Institute on Drug Abuse [Grant R01 DA 024865] (KAB) and Training Grant T32 DA031115] (LCS); National Institute of General Medical Sciences [Grant R01 GM106035] (KAB); and the National Institute of Neurological Disorders and Stroke [Training Grant T32 NS082145] (M.M.P.). The authors regret this error and any inconvenience it may have caused.

Original language	English (US)
Number of pages	1
Journal	Journal of Pharmacology and Experimental Therapeutics
DOIs	https://doi.org/10.1124/jpet.112.241604err
State	Published - Apr 1 2019
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Molecular Medicine
Pharmacology

Cite this

Sullivan, L. C., Chavera, T. A., Gao, X., Pando, M. M., & Berg, K. A. (2019). Correction to: Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604). Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.112.241604err

Correction to : Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604). / Sullivan, L. C.; Chavera, T. A.; Gao, X.; Pando, M. M.; Berg, Kelly A.

In: Journal of Pharmacology and Experimental Therapeutics, 01.04.2019.

Research output: Contribution to journal › Comment/debate

Sullivan, LC, Chavera, TA, Gao, X, Pando, MM & Berg, KA 2019, 'Correction to: Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604)', Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.112.241604err

Sullivan LC, Chavera TA, Gao X, Pando MM, Berg KA. Correction to: Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604). Journal of Pharmacology and Experimental Therapeutics. 2019 Apr 1. https://doi.org/10.1124/jpet.112.241604err

Sullivan, L. C. ; Chavera, T. A. ; Gao, X. ; Pando, M. M. ; Berg, Kelly A. / Correction to : Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604). In: Journal of Pharmacology and Experimental Therapeutics. 2019.

@article{40bb274994954610bff1dfa8f3ea0c89,

title = "Correction to: Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604)",

abstract = "J Pharmacol Exp Ther 362(1):200–209; DOI: 10.1124/jpet.117.241604], the following funding information was omitted: This work was supported by U.S. Public Health Service grants from the National Institutes of Health National Institute on Drug Abuse [Grant R01 DA 024865] (KAB) and Training Grant T32 DA031115] (LCS); National Institute of General Medical Sciences [Grant R01 GM106035] (KAB); and the National Institute of Neurological Disorders and Stroke [Training Grant T32 NS082145] (M.M.P.). The authors regret this error and any inconvenience it may have caused.",

author = "Sullivan, {L. C.} and Chavera, {T. A.} and X. Gao and Pando, {M. M.} and Berg, {Kelly A}",

year = "2019",

month = apr

day = "1",

doi = "10.1124/jpet.112.241604err",

language = "English (US)",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "0022-3565",

publisher = "American Society for Pharmacology and Experimental Therapeutics",

}

TY - JOUR

T1 - Correction to

T2 - Regulation of D opioid receptor-mediated signaling and antinociception in peripheral sensory neurons by arachidonic acid–dependent 12/15-lipoxygenase metabolites (Journal of Pharmacology and Experimental Therapeutics (2017) 362:1 (200–209) DOI: 10.1124/jpet.117.241604)

AU - Sullivan, L. C.

AU - Chavera, T. A.

AU - Gao, X.

AU - Pando, M. M.

AU - Berg, Kelly A

PY - 2019/4/1

Y1 - 2019/4/1

N2 - J Pharmacol Exp Ther 362(1):200–209; DOI: 10.1124/jpet.117.241604], the following funding information was omitted: This work was supported by U.S. Public Health Service grants from the National Institutes of Health National Institute on Drug Abuse [Grant R01 DA 024865] (KAB) and Training Grant T32 DA031115] (LCS); National Institute of General Medical Sciences [Grant R01 GM106035] (KAB); and the National Institute of Neurological Disorders and Stroke [Training Grant T32 NS082145] (M.M.P.). The authors regret this error and any inconvenience it may have caused.

AB - J Pharmacol Exp Ther 362(1):200–209; DOI: 10.1124/jpet.117.241604], the following funding information was omitted: This work was supported by U.S. Public Health Service grants from the National Institutes of Health National Institute on Drug Abuse [Grant R01 DA 024865] (KAB) and Training Grant T32 DA031115] (LCS); National Institute of General Medical Sciences [Grant R01 GM106035] (KAB); and the National Institute of Neurological Disorders and Stroke [Training Grant T32 NS082145] (M.M.P.). The authors regret this error and any inconvenience it may have caused.

UR - http://www.scopus.com/inward/record.url?scp=85063268924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063268924&partnerID=8YFLogxK

U2 - 10.1124/jpet.112.241604err

DO - 10.1124/jpet.112.241604err

M3 - Comment/debate

C2 - 30886002

AN - SCOPUS:85063268924

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

ER -

Access to Document

10.1124/jpet.112.241604err